NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,217 | -2.6% | 1,273 | 0.0% | 0.00% | – |
| Q2 2023 | $9,459 | +13.0% | 1,273 | +5.4% | 0.00% | – |
| Q1 2023 | $8,372 | -32.6% | 1,208 | 0.0% | 0.00% | – |
| Q4 2022 | $12,418 | -43.6% | 1,208 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $22,000 | -64.5% | 1,208 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $62,000 | -30.3% | 1,208 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $89,000 | -48.6% | 1,208 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $173,000 | -30.5% | 1,208 | +0.8% | 0.00% | -33.3% |
| Q3 2021 | $249,000 | -16.2% | 1,199 | -14.3% | 0.01% | -14.3% |
| Q2 2021 | $297,000 | +16.9% | 1,399 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $254,000 | +62.8% | 1,399 | 0.0% | 0.01% | +75.0% |
| Q4 2020 | $156,000 | +3.3% | 1,399 | +0.3% | 0.00% | -20.0% |
| Q3 2020 | $151,000 | +30.2% | 1,395 | 0.0% | 0.01% | +25.0% |
| Q2 2020 | $116,000 | +625.0% | 1,395 | +16.2% | 0.00% | +300.0% |
| Q1 2020 | $16,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |